These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis. Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, Sartorelli S, Sabbadini MG, Papa M, De Cobelli F, Mason JC, Gianolli L, Manfredi AA, Picchio M. Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1109-1118. PubMed ID: 28180963 [Abstract] [Full Text] [Related]
25. Assessment of inflammatory activity in Takayasu's arteritis: performance of clinical scores and common biomarkers versus 18F-FDG PET/CT. Jiménez D, Soto ME, Martínez-Martínez LA, Hernández-López D, Lerma C, Barragán-Garfias JA, Pérez-Torres I, Hernández-Lemus E, Guarner-Lans V. Clin Exp Rheumatol; 2021 Jul; 39(5):1011-1020. PubMed ID: 33124558 [Abstract] [Full Text] [Related]
26. Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT. Kaida H, Tahara N, Tahara A, Honda A, Nitta Y, Igata S, Ishibashi M, Yamagishi S, Fukumoto Y. Atherosclerosis; 2014 Dec; 237(2):404-9. PubMed ID: 25463065 [Abstract] [Full Text] [Related]
28. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):674-81. PubMed ID: 15747154 [Abstract] [Full Text] [Related]
30. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, Di Palo A, Angiletta D, Regina G, Marzullo A, Rubini G. Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136 [Abstract] [Full Text] [Related]
31. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, Lawler MA, Grinspoon SK, Brady TJ, Nasir K, Hoffmann U, Tawakol A. JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261 [Abstract] [Full Text] [Related]
34. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Webb M, Chambers A, AL-Nahhas A, Mason JC, Maudlin L, Rahman L, Frank J. Eur J Nucl Med Mol Imaging; 2004 May; 31(5):627-34. PubMed ID: 14730404 [Abstract] [Full Text] [Related]
35. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters. Thuermel K, Einspieler I, Wolfram S, Moog P, Meier R, Schwaiger M, Heemann U. Clin Exp Rheumatol; 2017 May; 35 Suppl 103(1):146-154. PubMed ID: 27974103 [Abstract] [Full Text] [Related]
37. Association between carotid 18F-NaF and 18F-FDG uptake on PET/CT with ischemic vascular brain disease on MRI in patients with carotid artery disease. Fujimoto K, Norikane T, Yamamoto Y, Takami Y, Mitamura K, Okada M, Hatakeyama T, Kawanishi M, Nishiyama Y. Ann Nucl Med; 2019 Dec; 33(12):907-915. PubMed ID: 31571042 [Abstract] [Full Text] [Related]
38. Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT. Lensen KDF, van Sijl AM, Voskuyl AE, van der Laken CJ, Heymans MW, Comans EFI, Nurmohamed MT, Smulders YM, Boellaard R. PLoS One; 2017 Dec; 12(8):e0181847. PubMed ID: 28800625 [Abstract] [Full Text] [Related]